RSA 키 (2048)

-----BEGIN PRIVATE KEY----- MIIEvQIBADANBgkqhkiG9w0BAQEFAASCBKcwggSjAgEAAoIBAQCpXBjekQUQX14X er5q65shzrRpazKgrJwGIke0q+dfu4vgnjRFzgyKGbYJtlQZLczfM+ShAINHYier X2EUKLXVDojoKRC1ADC1T15dQ5IEg6/wlQGQ6d4vB2P7CDhpbG067iqM0GQYwVJw I+FOq1rvUkJL4xl7fEkCAnTOkGy+tmEMwgL6So1UNFZJsVtYt4OUgNvVOSHWbZbX xFUl3A7NCcO/i+b7me6+BN3wcsbkMjKHX3XTKBYmhTPKx8JHrhi93FFueypUZPN+ twALURxS1AUnArf+qRc+hpnaabWMCq4greb1MWsx+9SeG0lk5HYwXxlX3ox8B0vl lKL+fRITAgMBAAECggEAUGrRyEUWIXsXQ5DeAAkV5YywL+pd5NtxTpxSbiC+Qb/d IHAepBK984lX3e68qiQMRuPuKOEEdQ3PhllI0HiwNpWrPonZTAjmGAGy7hgaqpgZ H+SxFK1n+e7Jc7aoiq6Yg0X54FlHXlXVnjf7UQ6epErr/fq869zNEe42pqr/Z+KO DpHeAJ2rnULAFrVaV86lQXBJf4C/qixyfSfZAEop7s5ohkG+A1VT7oThJjg+2zNg KY73wAlpCyue9tY5wyfmLk1rMldHatD9YRPvdyLdrAW/RxFpUGtlp7R5cHv/T+63 lcgWXCHcPxabqqT7EFTZZSQ4ikBj2tPz7ScpZ+DAgQKBgQDVg4k37SMsusfaNaJ1 UEex1D2BttPdBgbamk16wHVXFMWxWc4cDhXK+estavSS12aqqS4aSacl5Ua81BJt S95qjTJM0pL5XCSKVW7hE6AZuGhn8hWfvFBDbi77k2irTgGcEuMwElJcjL23CJnD MI+L60MtEKPFuAszQtPFh5500wKBgQDLD1a/05RPgVeDMt74e9A3ftmPWIe2M0p9 A7x7FTl8klStrNMBrsMBG+2IUVvGXNIEuMtMGJG0EsZ9EGGyU5DiiJeUDmQd9zyE nubDpyjfI8ZIsHlchiCbYzVpTq8bG3FclOw8dTXgXRsUuvB6LLssLj4bTASaqV2M mG2snXmlwQKBgQCuG/8Pbf7bAMzr8gSyaW6tYodteWs2ty1roZxA1yRYiIXVY4gh dJLs2/OdK7SY8bG0xRTlNt5olpiibsU//zg150H3R1e2pB7f917dh6Vsk+X/rXdY tLU252jEmaYm2wuQ/A3rK2WiNtqVoRvSAY1s6cHzw7fpCXWIrZwHXdonJQKBgDWy ybsSxa68wprEcih9/ZMfbYM14zWwnKswuMBH3Zruy4veHzLbt1/stcUN1to/I57y C3kFKkrXiDv8gAl7hd4SRxt1Ls6p2gwsRVRKOUnBGSeR25Y3NhpBgxdlInNlr3XP QCXAzU2W8Zlq0jtM5vaJCA2J7dHEpiOPD7nNLyVBAoGANJYaPdqr1lCDBMi2A0Ma tiUk9o1pKN8i/D2jlo+RG53TRVrN790hEcO/M3RIG0Oa8w8O85AgJ+BNBT/CUpYv gj1M9OGlZHRrAm1L6l4FvS5CcF0ABjzZeWyNg+XzRKriKy6r76OMwYAgl86UQCS7 xGICsLnpSYJrylE9huG9mMA= -----END PRIVATE KEY-----


-----BEGIN PUBLIC KEY----- MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAqVwY3pEFEF9eF3q+auub Ic60aWsyoKycBiJHtKvnX7uL4J40Rc4Mihm2CbZUGS3M3zPkoQCDR2Inq19hFCi1 1Q6I6CkQtQAwtU9eXUOSBIOv8JUBkOneLwdj+wg4aWxtOu4qjNBkGMFScCPhTqta 71JCS+MZe3xJAgJ0zpBsvrZhDMIC+kqNVDRWSbFbWLeDlIDb1Tkh1m2W18RVJdwO zQnDv4vm+5nuvgTd8HLG5DIyh1910ygWJoUzysfCR64YvdxRbnsqVGTzfrcAC1Ec UtQFJwK3/qkXPoaZ2mm1jAquIK3m9TFrMfvUnhtJZOR2MF8ZV96MfAdL5ZSi/n0S EwIDAQAB -----END PUBLIC KEY-----

자유게시판

CS Center

tel. 02-715-4734

am 10:00 ~ pm 6:00

공휴일 휴관
(사전예약 후 관람가능)

010-5217-9505
orbgallery@naver.com

Total of 1000 ml or more during the first 6 h. However, the

페이지 정보

profile_image
작성자 Therese
댓글 0건 조회 6회 작성일 23-12-15 10:18

본문

Total of 1000 ml or more during the first 6 h. However, the decision regarding haemorrhagic reexploration was made by the surgeon in charge. Chest tube outputs were used as a measure of blood loss, and our analysis was based on the total volume of loss during the first 24 h of the patient's stay in the ICU. Post-operative acute kidney injury (AKI) was defined according to the consensus RIFLE criteria (risk, injury, failure, loss of function, and end-stage renal disease) using the maximal change in serum creatinine and estimated glomerular filtration rate during the first 7 post-operative days compared with preoperative baseline values [22].Statistical analysisprevalence of a covariate between treatment groups (Fig. 1) [23, 24]. Finally, the significance within the models was evaluated with the Wald test, whereas the strength of the association of variables with post-operative outcomes was estimated by calculating the odds ratio (OR), the unstandardised coefficient and 95 confidence intervals (CIs). The model was calibrated using the Hosmer-Lemeshow goodness-of-fit test, as well as residual diagnostics (deviance and degrees of freedom of values). Model discrimination was evaluated by using the area under the ROC curve. All tests were two-sided with the level set at 0.05 for statistical significance. Statistical analysis was performed using IBM SPSS version 22.0 software (IBM, Armonk, NY, USA).ResultsStudy populationClinical data were prospectively recorded and tabulated using Microsoft Excel PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9282946 software (Microsoft, Redmond, (2-methoxy-5-methylphenyl)boronic acid 2-(2-Aminoethoxy)-5-chloropyridine hydrochloride WA, USA). Continuous data are reported as mean and standard deviation or median and interquartile range (IQR), as appropriate. Nominal variables were reported as counts and percentages. Fisher's exact test, 2 test and the Mann-Whitney U test were used for univariate analysis. No attempt to replace missing values was made. Multivariate analysis was performed using logistic and linear regression. The area under the receiver operating characteristic (ROC) curve was used to represent PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25116583 the regression probabilities. Since January 2012, PCC has been used systematically as first-line therapy in coagulation management, completely replacing FFP, and this PCC use was consistently followed. Therefore, the PCC study group was matched with the historical series of patients who received FFP before this time point. Because the study groups (i.e., the PCC and the FFP groups) significantly differed in a number of baseline and operative variables, a propensity score was calculated by logistic regression to estimate the probability of being assigned to each of the study treatments. The propensity score was calculated in a non-parsimonious way, including all 31 pre-operative and operative variables listed in Tables 1 and 2. The obtained propensity score was used for adjusted analysis in the overall series and for one-to-one propensity score caliper matching. The caliper width chosen was 0.2 times the standard deviation of the logit of the propensity score (i.e., 0.01). Propensity score was used as a covariate, along with the treatment method, in the multivariate analysis model for each outcome end-point. After the propensity score matching was performed, differences between the two groups were assessed. Absolute standardised differences were estimated to evaluate the pre-match and post-match imbalance, and a standardised difference <0.1 was considered a negligible difference in the mean orAmong the 3454 included patients (mean age 68.0.

댓글목록

등록된 댓글이 없습니다.